233.
Hood AF, Lumadue J. Benign vulvar tumors. Dermatol Clin 1992; 10:371–385.
234.
Trager JD. Pubic hair removal—pearls and pitfalls. J Pediatr Adolesc Gynecol 2006;19:117–123.
235.
Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009;60:539–563.
236. Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol 2004;5:199–203.
237.
Higgins SP, Freemark M, Prose NS. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J 2008;14:2.
238.
Kaufman R, Faro S, Brown D, eds. Cystic tumors in Benign diseases of the vulva and vagina. 5 ed. Philadelphia: Elsevier Mosby, 2005:449.
239.
Word B. Office treatment of cysts and abscess of Bartholin’s gland duct. South Med J 1968;61(5): 514-8.
240.
Farage MA, Galask RP. Vulvar vestibulitis syndrome: a review. Eur J Obstet Gynecol Reprod Biol 2005;123:9–16.
241.
Petersen CD, Lundvall L, Kristensen E, et al. Vulvodynia. Definition, diagnosis and treatment. Acta Obstet Gynecol Scand 2008; 87:893–901.
242.
Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med 2004;49:772–777.
243.
Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med 1987;32:110–114.
244.
Sakane T, Takeno M, Suzuki N, et al. Behcet’s disease. N Engl J Med 1999;341:1284–1291.
245.
Gul A. Standard and novel therapeutic approaches to Behcet’s disease. Drugs 2007;67:2013–2022.
246.
Furness S, Roberts H, Marjoribanks J, et al. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev 2009;2:CD000402.
247.
Sitruk-Ware R. New hormonal therapies and regimens in the post-menopause: routes of administration and timing of initiation. Climacteric 2007;10:358–370.
248.
Kenemans P, van Unnik GA, Mijatovic V, et al. Perspectives in hormone replacement therapy. Maturitas 2001;38(Suppl 1):S41– S48.
249.
Shoupe D. HRT dosing regimens: continuous versus cyclic-pros and cons. Int J Fertil Womens Med 2001;46:7–15.
250.